StonvexLoading…
StonvexStonvexStonvexCore line items from CPSS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $434.47M | $393.51M | $352.01M | $329.71M |
Operating Income | $28.00M | $27.43M | $61.10M | $116.19M |
Net Income | $19.32M | $19.20M | $45.34M | $85.98M |
EPS (Diluted) | $0.80 | $0.79 | $1.80 | $3.23 |
Total Assets | $3.86B | $3.49B | $2.90B | $2.75B |
Total Liabilities | $3.55B | $3.20B | $2.63B | $2.52B |
Cash & Equivalents | $6.32M | $11.71M | $6.17M | $13.49M |
Free Cash Flow OCF − CapEx | $288.29M | $233.32M | $237.42M | $213.78M |
Shares Outstanding | 21.84M | 21.43M | 21.17M | 20.13M |